PERS MED 润色咨询

Personalized Medicine

出版年份:2004 年文章数:439 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:18.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审,大概多长时间?<span class="quote">mgn6022_62675333 2019-10-10 发表::<br>接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span><span class="quote">mgn6022_62675333 2019-10-10 12:52:00 发表:<br>杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span>, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费<span class="quote">187N4h36293(暂无昵称) 2018-10-06 发表::<br>请问这个杂志收版面费吗? </span><span class="quote">187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表:<br>请问这个杂志收版面费吗? <br> </span>, beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine,3周了,一直显示under consideration。我这个状态是不是还没外审啊,后续这个期刊还会不会出现Under Review等一般期刊的常用语吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了,年文章才48篇,进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:原来投了他一个系列的杂志叫biomarkers in medicine,编辑说该pm可以考虑,考虑了几天,还是接受了,说来这杂志的所谓PM概念还是蛮吸引人的,怎么if就那么低呢,不应该啊,可能是每年文章太少了吧,我也见过发了好多hepatology和JH的大牛在上面发社论的,不知道了,随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]
    2021-12-29 Gym璨烨

    我是写那种格式的摘要比较好?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审,大概多长时间?<span class="quote">mgn6022_62675333 2019-10-10 发表::<br>接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span><span class="quote">mgn6022_62675333 2019-10-10 12:52:00 发表:<br>杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span>, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费<span class="quote">187N4h36293(暂无昵称) 2018-10-06 发表::<br>请问这个杂志收版面费吗? </span><span class="quote">187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表:<br>请问这个杂志收版面费吗? <br> </span>, beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine,3周了,一直显示under consideration。我这个状态是不是还没外审啊,后续这个期刊还会不会出现Under Review等一般期刊的常用语吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了,年文章才48篇,进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:原来投了他一个系列的杂志叫biomarkers in medicine,编辑说该pm可以考虑,考虑了几天,还是接受了,说来这杂志的所谓PM概念还是蛮吸引人的,怎么if就那么低呢,不应该啊,可能是每年文章太少了吧,我也见过发了好多hepatology和JH的大牛在上面发社论的,不知道了,随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]
    2021-12-27 ms6000000264964247

    摘要一般有什么要求?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审,大概多长时间?<span class="quote">mgn6022_62675333 2019-10-10 发表::<br>接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span><span class="quote">mgn6022_62675333 2019-10-10 12:52:00 发表:<br>杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span>, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费<span class="quote">187N4h36293(暂无昵称) 2018-10-06 发表::<br>请问这个杂志收版面费吗? </span><span class="quote">187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表:<br>请问这个杂志收版面费吗? <br> </span>, beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine,3周了,一直显示under consideration。我这个状态是不是还没外审啊,后续这个期刊还会不会出现Under Review等一般期刊的常用语吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了,年文章才48篇,进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:原来投了他一个系列的杂志叫biomarkers in medicine,编辑说该pm可以考虑,考虑了几天,还是接受了,说来这杂志的所谓PM概念还是蛮吸引人的,怎么if就那么低呢,不应该啊,可能是每年文章太少了吧,我也见过发了好多hepatology和JH的大牛在上面发社论的,不知道了,随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]
    2020-03-30 红土之王

    这个一审,大概多长时间?mgn6022_62675333 2019-10-10 发表::
    接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章
    mgn6022_62675333 2019-10-10 12:52:00 发表:
    杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章

    mgn6022_62675333 2019-10-10 发表:: 接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审,大概多长时间?<span class="quote">mgn6022_62675333 2019-10-10 发表::<br>接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span><span class="quote">mgn6022_62675333 2019-10-10 12:52:00 发表:<br>杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span>, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费<span class="quote">187N4h36293(暂无昵称) 2018-10-06 发表::<br>请问这个杂志收版面费吗? </span><span class="quote">187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表:<br>请问这个杂志收版面费吗? <br> </span>, beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine,3周了,一直显示under consideration。我这个状态是不是还没外审啊,后续这个期刊还会不会出现Under Review等一般期刊的常用语吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了,年文章才48篇,进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:原来投了他一个系列的杂志叫biomarkers in medicine,编辑说该pm可以考虑,考虑了几天,还是接受了,说来这杂志的所谓PM概念还是蛮吸引人的,怎么if就那么低呢,不应该啊,可能是每年文章太少了吧,我也见过发了好多hepatology和JH的大牛在上面发社论的,不知道了,随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]
    2019-10-10 mgn6022_62675333

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享:杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审,大概多长时间?<span class="quote">mgn6022_62675333 2019-10-10 发表::<br>接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span><span class="quote">mgn6022_62675333 2019-10-10 12:52:00 发表:<br>杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span>, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费<span class="quote">187N4h36293(暂无昵称) 2018-10-06 发表::<br>请问这个杂志收版面费吗? </span><span class="quote">187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表:<br>请问这个杂志收版面费吗? <br> </span>, beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine,3周了,一直显示under consideration。我这个状态是不是还没外审啊,后续这个期刊还会不会出现Under Review等一般期刊的常用语吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了,年文章才48篇,进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:原来投了他一个系列的杂志叫biomarkers in medicine,编辑说该pm可以考虑,考虑了几天,还是接受了,说来这杂志的所谓PM概念还是蛮吸引人的,怎么if就那么低呢,不应该啊,可能是每年文章太少了吧,我也见过发了好多hepatology和JH的大牛在上面发社论的,不知道了,随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]
    2018-12-18 1222ec6bm09暂无昵称

    可以选择收费和不收费187N4h36293(暂无昵称) 2018-10-06 发表::
    请问这个杂志收版面费吗?
    187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表:
    请问这个杂志收版面费吗?

    187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗?

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审,大概多长时间?<span class="quote">mgn6022_62675333 2019-10-10 发表::<br>接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span><span class="quote">mgn6022_62675333 2019-10-10 12:52:00 发表:<br>杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span>, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费<span class="quote">187N4h36293(暂无昵称) 2018-10-06 发表::<br>请问这个杂志收版面费吗? </span><span class="quote">187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表:<br>请问这个杂志收版面费吗? <br> </span>, beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine,3周了,一直显示under consideration。我这个状态是不是还没外审啊,后续这个期刊还会不会出现Under Review等一般期刊的常用语吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了,年文章才48篇,进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:原来投了他一个系列的杂志叫biomarkers in medicine,编辑说该pm可以考虑,考虑了几天,还是接受了,说来这杂志的所谓PM概念还是蛮吸引人的,怎么if就那么低呢,不应该啊,可能是每年文章太少了吧,我也见过发了好多hepatology和JH的大牛在上面发社论的,不知道了,随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]
    2018-10-06 122c6d6cm93(暂无昵称)

    请问这个杂志收版面费吗?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审,大概多长时间?<span class="quote">mgn6022_62675333 2019-10-10 发表::<br>接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span><span class="quote">mgn6022_62675333 2019-10-10 12:52:00 发表:<br>杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span>, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费<span class="quote">187N4h36293(暂无昵称) 2018-10-06 发表::<br>请问这个杂志收版面费吗? </span><span class="quote">187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表:<br>请问这个杂志收版面费吗? <br> </span>, beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine,3周了,一直显示under consideration。我这个状态是不是还没外审啊,后续这个期刊还会不会出现Under Review等一般期刊的常用语吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了,年文章才48篇,进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:原来投了他一个系列的杂志叫biomarkers in medicine,编辑说该pm可以考虑,考虑了几天,还是接受了,说来这杂志的所谓PM概念还是蛮吸引人的,怎么if就那么低呢,不应该啊,可能是每年文章太少了吧,我也见过发了好多hepatology和JH的大牛在上面发社论的,不知道了,随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]
    2018-06-25 huihuiswd

    我最近也投了Personalized Medicine,3周了,一直显示under consideration。我这个状态是不是还没外审啊,后续这个期刊还会不会出现Under Review等一般期刊的常用语吗?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审,大概多长时间?<span class="quote">mgn6022_62675333 2019-10-10 发表::<br>接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span><span class="quote">mgn6022_62675333 2019-10-10 12:52:00 发表:<br>杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span>, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费<span class="quote">187N4h36293(暂无昵称) 2018-10-06 发表::<br>请问这个杂志收版面费吗? </span><span class="quote">187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表:<br>请问这个杂志收版面费吗? <br> </span>, beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine,3周了,一直显示under consideration。我这个状态是不是还没外审啊,后续这个期刊还会不会出现Under Review等一般期刊的常用语吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了,年文章才48篇,进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:原来投了他一个系列的杂志叫biomarkers in medicine,编辑说该pm可以考虑,考虑了几天,还是接受了,说来这杂志的所谓PM概念还是蛮吸引人的,怎么if就那么低呢,不应该啊,可能是每年文章太少了吧,我也见过发了好多hepatology和JH的大牛在上面发社论的,不知道了,随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]
    2017-03-23 changer11

    投了之后就后悔了,年文章才48篇,进了神坑

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1100591, encodeId=9f2611005916c, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1100592, encodeId=16b21100592c8, content=摘要一般有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587725, encodeId=f18158e72509, content=这个一审,大概多长时间?<span class="quote">mgn6022_62675333 2019-10-10 发表::<br>接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span><span class="quote">mgn6022_62675333 2019-10-10 12:52:00 发表:<br>杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章</span>, beContent=mgn6022_62675333 2019-10-10 发表:: 接收率:约50% 审稿时间:约12个月 杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ae71975661, createdName=红土之王, createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577635, encodeId=093d5e7635cc, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:杂志不收费,但是审稿效率非常非常慢,去年投的文章,过了一年终于到校样环节了,续后发表还不知道是什么时候;适合不那么着急发表的文章, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/19ace8f5f28bc513a3a0232182ee43b4/3adda64451a4e127fa1b6cf4ca9072f8.jpg, createdBy=402c5204572, createdName=mgn6022_62675333, createdTime=Thu Oct 10 12:52:00 CST 2019, time=2019-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564618, encodeId=5e82564618af, content=可以选择收费和不收费<span class="quote">187N4h36293(暂无昵称) 2018-10-06 发表::<br>请问这个杂志收版面费吗? </span><span class="quote">187N4h36293(暂无昵称) 2018-10-06 19:54:00 发表:<br>请问这个杂志收版面费吗? <br> </span>, beContent=187N4h36293(暂无昵称) 2018-10-06 发表:: 请问这个杂志收版面费吗? , objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b1f2312945, createdName=1222ec6bm09暂无昵称, createdTime=Tue Dec 18 00:00:00 CST 2018, time=2018-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561726, encodeId=088c561e26e1, content=请问这个杂志收版面费吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03fc2358255, createdName=122c6d6cm93(暂无昵称), createdTime=Sat Oct 06 19:54:00 CST 2018, time=2018-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558274, encodeId=18475582e443, content=我最近也投了Personalized Medicine,3周了,一直显示under consideration。我这个状态是不是还没外审啊,后续这个期刊还会不会出现Under Review等一般期刊的常用语吗? <br> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=235, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e771665320, createdName=huihuiswd, createdTime=Mon Jun 25 09:19:00 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534583, encodeId=484c53458310, content=投了之后就后悔了,年文章才48篇,进了神坑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=24e71740290, createdName=changer11, createdTime=Thu Mar 23 08:32:00 CST 2017, time=2017-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506219, encodeId=cf0450621983, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:原来投了他一个系列的杂志叫biomarkers in medicine,编辑说该pm可以考虑,考虑了几天,还是接受了,说来这杂志的所谓PM概念还是蛮吸引人的,怎么if就那么低呢,不应该啊,可能是每年文章太少了吧,我也见过发了好多hepatology和JH的大牛在上面发社论的,不知道了,随便说说, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=296, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zjuliew, createdTime=Tue Sep 23 01:16:00 CST 2014, time=2014-09-23, status=1, ipAttribution=)]
    2014-09-23 zjuliew

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:原来投了他一个系列的杂志叫biomarkers in medicine,编辑说该pm可以考虑,考虑了几天,还是接受了,说来这杂志的所谓PM概念还是蛮吸引人的,怎么if就那么低呢,不应该啊,可能是每年文章太少了吧,我也见过发了好多hepatology和JH的大牛在上面发社论的,不知道了,随便说说

    0

共11条页码: 1/2页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分